Autoantigens are self-derived molecules that become recognized by the adaptive immune system after tolerance is lost. They may be intracellular enzymes, nuclear ribonucleoproteins, membrane receptors, structural matrix proteins, microbial-response proteins, or tissue-restricted differentiation antigens. In autoimmune and immune-mediated diseases, the target profile is not simply a diagnostic label; it reflects the tissue compartment exposed to inflammation, the route of antigen presentation, the immunoglobulin class or subclass involved, and the effector mechanisms that translate autoantibody binding into tissue injury. For reagent development, assay design, and mechanistic research, each autoantigen should therefore be considered in relation to its native localization, conformational state, post-translational modification, biological function, and disease-associated epitope pattern.
Idiopathic inflammatory myopathies are systemic autoimmune diseases in which autoantibody profiles define clinically meaningful subsets. Myositis-specific antibodies target aminoacyl-tRNA synthetases, RNA helicases, transcriptional regulators, signal recognition particle components, ubiquitination-related proteins, and muscle-associated enzymes. These targets correlate with phenotypes such as antisynthetase syndrome, dermatomyositis, immune-mediated necrotizing myopathy, cancer-associated myositis, interstitial lung disease, and overlap connective tissue disease. The antigen list is broad because myositis autoimmunity is not restricted to a single tissue compartment; many targets are ubiquitous intracellular proteins whose immune recognition maps to distinct clinical syndromes.
Several recurring mechanisms explain how normally tolerated proteins become immunogenic. Cell stress, apoptosis, necrosis, degranulation, extracellular trap formation, defective clearance of immune complexes, microbial mimicry, and oxidative or enzymatic modification can all increase antigen availability. Once antigen is released or redistributed, antigen-presenting cells process peptides and activate autoreactive T cells. B cells receiving T-cell help undergo clonal expansion, affinity maturation, and class switching, producing antibodies that may serve as biomarkers, pathogenic mediators, or both. The clinical value of an autoantigen depends on antigen quality: recombinant proteins should preserve relevant epitopes, native proteins may retain conformational and post-translational features, and peptide antigens are useful when the dominant epitope is linear and well defined.
Fig. 1 Mechanisms of Immunogenicity in Myositis
The classical and commonly used targets for this material document include:
These targets should be selected according to the intended research question, assay platform, desired sensitivity and specificity, sample matrix, and whether the study requires native conformational epitopes, recombinant full-length protein, antigenic domains, or synthetic peptide epitopes.
| Target | Location | Function | Immunological Role |
| Jo-1 / histidyl-tRNA synthetase | Cytoplasm | Charges histidine onto tRNA for protein synthesis | Most common antisynthetase antibody target |
| PL-7 / threonyl-tRNA synthetase | Cytoplasm | Charges threonine onto tRNA | Antisynthetase syndrome target |
| PL-12 / alanyl-tRNA synthetase | Cytoplasm | Charges alanine onto tRNA | Antisynthetase syndrome target |
| Mi-2 | Nuclear chromatin remodeling complex | Nucleosome remodeling and transcription regulation | Dermatomyositis-associated autoantigen |
| MDA5 / IFIH1 | Cytoplasmic viral RNA sensor | Innate antiviral recognition and interferon induction | Dermatomyositis target associated with rapidly progressive ILD in some populations |
| TIF1-gamma / TRIM33 | Nucleus | Transcription regulation and TGF-beta pathway modulation | Dermatomyositis marker associated with malignancy risk in adults |
| NXP2 | Nuclear matrix | Transcriptional and nuclear matrix regulation | Dermatomyositis target linked with calcinosis and severe muscle disease |
| SRP | Cytoplasmic ribonucleoprotein complex | Targets nascent proteins to endoplasmic reticulum | Immune-mediated necrotizing myopathy target |
| HMG-CoA reductase (HMGCR) | Endoplasmic reticulum membrane | Cholesterol biosynthesis enzyme | Necrotizing autoimmune myopathy target, sometimes statin-associated |
Anti-Jo-1 defines a subset with myositis, arthritis, mechanic hands, Raynaud phenomenon, and interstitial lung disease.
Localization and function: Jo-1 / histidyl-tRNA synthetase is primarily associated with cytoplasm. Its biological role centers on charges histidine onto trna for protein synthesis. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Most common antisynthetase antibody target. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-PL-7 is often linked with prominent interstitial lung disease and variable muscle involvement.
Localization and function: PL-7 / threonyl-tRNA synthetase is primarily associated with cytoplasm. Its biological role centers on charges threonine onto trna. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Antisynthetase syndrome target. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-PL-12 may present with lung-dominant disease, emphasizing the need for expanded synthetase panels.
Localization and function: PL-12 / alanyl-tRNA synthetase is primarily associated with cytoplasm. Its biological role centers on charges alanine onto trna. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Antisynthetase syndrome target. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-Mi-2 is associated with classic dermatomyositis rash and often favorable treatment response.
Localization and function: Mi-2 is primarily associated with nuclear chromatin remodeling complex. Its biological role centers on nucleosome remodeling and transcription regulation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Dermatomyositis-associated autoantigen. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-MDA5 connects antiviral sensing pathways with severe cutaneous and pulmonary disease phenotypes.
Localization and function: MDA5 / IFIH1 is primarily associated with cytoplasmic viral rna sensor. Its biological role centers on innate antiviral recognition and interferon induction. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Dermatomyositis target associated with rapidly progressive ILD in some populations. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-TIF1-gamma is important for cancer-associated myositis risk stratification.
Localization and function: TIF1-gamma / TRIM33 is primarily associated with nucleus. Its biological role centers on transcription regulation and tgf-beta pathway modulation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Dermatomyositis marker associated with malignancy risk in adults. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-NXP2 appears in pediatric and adult dermatomyositis and may correlate with distinct complications.
Localization and function: NXP2 is primarily associated with nuclear matrix. Its biological role centers on transcriptional and nuclear matrix regulation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Dermatomyositis target linked with calcinosis and severe muscle disease. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-SRP antibodies are associated with severe weakness, high creatine kinase, and necrotizing muscle pathology.
Localization and function: SRP is primarily associated with cytoplasmic ribonucleoprotein complex. Its biological role centers on targets nascent proteins to endoplasmic reticulum. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Immune-mediated necrotizing myopathy target. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-HMGCR antibodies recognize a metabolic enzyme upregulated in regenerating muscle fibers.
Localization and function: HMG-CoA reductase (HMGCR) is primarily associated with endoplasmic reticulum membrane. Its biological role centers on cholesterol biosynthesis enzyme. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Necrotizing autoimmune myopathy target, sometimes statin-associated. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
References
